palladium has been researched along with Granulocytic Leukemia, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eslami Moghadam, M; Hosseini, SA; Saboury, AA; Saeidifar, M | 1 |
| Hartley, JA; Hazrati, A; Hursthouse, MB; Kotha, AK; Male, L; Motukuri, M; Rathnam, RP; Richardson, SC; Spencer, J | 1 |
2 other study(ies) available for palladium and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Biological effect and molecular docking of anticancer palladium and platinum complexes with morpholine dithiocarbamate on human serum albumin as a blood carrier protein.
Topics: Antineoplastic Agents; Blood Proteins; Carrier Proteins; Cell Line, Tumor; Circular Dichroism; Cisplatin; Drug Interactions; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Docking Simulation; Morpholines; Organoplatinum Compounds; Palladium; Protein Binding; Serum Albumin, Human | 2018 |
Synthesis of a 1,4-benzodiazepine containing palladacycle with in vitro anticancer and cathepsin B activity.
Topics: Animals; Antineoplastic Agents; Benzodiazepines; Cathepsin B; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chlorocebus aethiops; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Palladium; Vero Cells | 2009 |